Cost of disease progression among US patients with human epidermal growth factor receptor 2-positive metastatic breast cancer

• Main Authors: Clara Lam (Author), Brandon Diessner (Author), Katherine Andrade (Author), Sydnie Stackland (Author), Leah Park (Author), Sandhya Mehta (Author), Feng Lin (Author), Winghan Jackie Kwong (Author)
• Format: Book
• Published: Becaris Publishing Limited, 2024-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Aim: The objectives were to investigate the differences in per patient per month (PPPM) healthcare resource utilization (HCRU) and costs among commercially insured and Medicare Advantage patients with human epidermal growth factor receptor 2 positive (HER2+) metastatic breast cancer (mBC) who experi...